Why DroneShield, Imricor, Paladin Energy, and Silex shares are pushing higher

These shares are avoiding the market weakness and are pushing higher.

| More on:
Ecstatic woman looking at her phone outside with her fist pumped.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • DroneShield shares are currently up 3% following news of surpassing 4,000 systems sold and securing substantial contracts with the U.S. Department of Defense.
  • Imricor Medical Systems shares are trading 8% higher after the announcement of the successful completion of its Human Factors study, advancing towards FDA approval.
  • Paladin Energy and Silex Systems are experiencing share price increases due to recent positive shifts in the nuclear sector and successful technology demonstrations, respectively.

The S&P/ASX 200 Index (ASX: XJO) is having a poor session on Thursday. In afternoon trade, the benchmark index is down 0.5% to 8,771.8 points.

Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:

DroneShield Ltd (ASX: DRO)

The DroneShield share price is up a further 3% to $3.29. Investors have been buying this counter drone technology company's shares this week after it released a sales update. DroneShield has surpassed 4,000 systems sold worldwide. This follows the receipt of a package of two standalone contracts totalling $7.9 million for handheld systems for delivery to the U.S. Department of Defense. Commenting on the news, DroneShield's US CEO, Matt McCrann, said: "Passing 4,000 systems in service is an important milestone for our team and our customers. It underlines the performance and dependability of our solutions in the field, and the trust placed in DroneShield by those who rely on them."

Imricor Medical Systems Inc (ASX: IMR)

The Imricor Medical Systems share price is up 8% to $1.52. This morning, this medical device company revealed that it has successfully completed its Human Factors (HF) study covering all devices that are currently under review by the U.S. FDA. Imricor's chair and CEO, Steve Wedan, commented: "The scale of this study cannot be overstated, having taken our team over a year from planning through execution. Completing human factors testing across our entire product portfolio is an extraordinary achievement and a clear demonstration of the strength and dedication of the Imricor team. It also marks a major milestone on our path to FDA approval and positions us strongly as we prepare to bring MRI-guided ablation to the United States."

Paladin Energy Ltd (ASX: PDN)

The Paladin Energy share price is up 6% to $8.22. This uranium stock has been charging higher this week amid positive industry news. This includes the US Energy Secretary Chris Wright revealing that his government hopes to see "rapid growth" in consumption of the nuclear fuel, and that the US needed to move away from reliance on Russian-enriched uranium. In addition, the International Atomic Energy Agency (IAEA) upgraded its global nuclear operational capacity estimates.

Silex Systems Ltd (ASX: SLX)

The Silex Systems share price is up a further 16% to $5.57. Investors have been buying this uranium technology company's shares this week after a big update. Silex advised that Global Laser Enrichment (GLE), the exclusive licensee of the SILEX uranium enrichment technology, has completed the large-scale enrichment demonstration testing campaign at its Test Loop facility in North Carolina. The release reveals that GLE has collected extensive performance data providing confidence that its laser-based uranium enrichment process will achieve TRL-6 demonstration status and can be commercially deployed.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »